These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37691350)

  • 1. Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.
    Whitfield HJ; Berthelet J; Mangiola S; Bell C; Anderson RL; Pal B; Yeo B; Papenfuss AT; Merino D; Davis MJ
    Clin Transl Med; 2023 Sep; 13(9):e1356. PubMed ID: 37691350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
    Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
    Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma.
    Laberiano-Fernandez C; Gan Q; Wang SM; Tamegnon A; Wistuba I; Yoon E; Roy-Chowdhuri S; Parra ER
    J Am Soc Cytopathol; 2024; 13(3):161-173. PubMed ID: 38519275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer.
    Wu YY; Hsu YL; Huang YC; Su YC; Wu KL; Chang CY; Ong CT; Lai JC; Shen TY; Lee TH; Hung JY; Tsai YM
    Theranostics; 2023; 13(13):4412-4429. PubMed ID: 37649596
    [No Abstract]   [Full Text] [Related]  

  • 5. Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
    Bruschini S; Pallocca M; Sperandio E; D'Ambrosio L; Ascenzi F; De Vitis C; Salvati V; Esposito A; Di Martino S; De Nicola F; Paolini F; Fattore L; Alessandrini G; Facciolo F; Foddai ML; Bassi M; Venuta F; D'Ascanio M; Ricci A; D' Andrilli A; Napoli C; Aurisicchio L; Fanciulli M; Rendina EA; Ciliberto G; Mancini R
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35584864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patients.
    Nieto JC; Zamora C; Porcel JM; Mulet M; Pajares V; Muñoz-Fernandez AM; Calvo N; Espinosa I; Pascual-García M; Bielsa S; Vidal S
    Sci Rep; 2019 Feb; 9(1):2996. PubMed ID: 30816121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells.
    Tsilioni I; Filippidis AS; Kerenidi T; Budanov AV; Zarogiannis SG; Gourgoulianis KI
    Clin Biochem; 2016 Jun; 49(9):726-728. PubMed ID: 26874199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the diagnosis and management of malignant pleural effusions.
    Heffner JE; Klein JS
    Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.
    Meiller C; Montagne F; Hirsch TZ; Caruso S; de Wolf J; Bayard Q; Assié JB; Meunier L; Blum Y; Quetel L; Gibault L; Pintilie E; Badoual C; Humez S; Galateau-Sallé F; Copin MC; Letouzé E; Scherpereel A; Zucman-Rossi J; Le Pimpec-Barthes F; Jaurand MC; Jean D
    Genome Med; 2021 Jul; 13(1):113. PubMed ID: 34261524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management.
    Grigoriadou GΙ; Esagian SM; Ryu HS; Nikas IP
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33139621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions.
    Korczyński P; Mierzejewski M; Krenke R; Safianowska A; Light RW
    Pol Arch Intern Med; 2018 Jun; 128(6):354-361. PubMed ID: 29968696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.
    Liu D; Lu Y; Hu Z; Wu N; Nie X; Xia Y; Han Y; Li Q; Zhu G; Bai C
    PLoS One; 2014; 9(2):e89946. PubMed ID: 24587142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
    Tang Y; Xu L
    J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
    Yang J; Lee OJ; Son SM; Woo CG; Jeong Y; Yang Y; Kwon J; Lee KH; Han HS
    Cancer Res Treat; 2018 Jul; 50(3):908-916. PubMed ID: 28934846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Malignant Pleural Effusion Resident CD8
    Dhupar R; Okusanya OT; Eisenberg SH; Monaco SE; Ruffin AT; Liu D; Luketich JD; Kammula US; Bruno TC; Lotze MT; Soloff AC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
    Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
    Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.